| |
| |
|
| Insider
Information: |
Richo Anna |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
36,867 |
|
|
Indirect Shares
|
15,479 |
|
|
| Direct
Value |
$10,225,800 |
|
|
|
Indirect Value
|
$3,603,324 |
|
|
| Total
Shares |
52,346 |
|
|
| Total
Value |
$13,829,124 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amgen Inc |
AMGN |
SVP & CCO |
2012-08-01 |
36,867 |
2012-08-01 |
12,598 |
Premium* |
|
|
Adamas Pharmaceuticals Inc |
ADMS |
Director |
2021-11-24 |
0 |
2020-08-29 |
0 |
Premium* |
|
|
Exelon Corp |
EXC |
Director |
2023-09-30 |
0 |
2024-03-31 |
2,881 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXC |
Exelon Corp |
Director |
– • – |
2024-03-31 |
4 |
A |
$36.48 |
$41,259 |
I/I |
1,131 |
2,881 |
0 |
- |
|
| EXC |
Exelon Corp |
Director |
– • – |
2023-12-31 |
4 |
A |
$39.21 |
$41,249 |
I/I |
1,052 |
1,732 |
0 |
- |
|
| EXC |
Exelon Corp |
Director |
– • – |
2023-09-30 |
4 |
A |
$40.58 |
$27,351 |
I/I |
674 |
674 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2021-11-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(25,000) |
0 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
25,000 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2020-08-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
% |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2020-08-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• • – |
2012-08-01 |
4 |
S |
$83.06 |
$425,698 |
I/I |
(5,125) |
10,256 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• • – |
2012-08-01 |
4 |
GA |
$0.00 |
$0 |
I/I |
5,125 |
15,381 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• • – |
2012-08-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,125 |
36,867 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• • – |
2012-08-01 |
4 |
OE |
$62.63 |
$320,979 |
D/D |
5,125 |
41,992 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• • – |
2012-07-27 |
4 |
OE |
$71.88 |
$566,055 |
D/D |
7,875 |
44,742 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• • – |
2012-07-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,875 |
36,867 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• • – |
2012-07-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
7,875 |
18,131 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• • – |
2012-07-27 |
4 |
S |
$81.81 |
$644,230 |
I/I |
(7,875) |
10,256 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-05-01 |
4 |
D |
$71.11 |
$164,193 |
D/D |
(2,309) |
37,122 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-05-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
641 |
36,481 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-05-01 |
4 |
GA |
$0.00 |
$0 |
I/I |
641 |
10,256 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-05-01 |
4 |
OE |
$42.13 |
$1,212,984 |
D/D |
22,950 |
56,481 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-05-01 |
4 |
S |
$70.76 |
$1,415,571 |
D/D |
(20,000) |
36,481 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-04-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
449 |
9,615 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-04-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
449 |
36,481 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-04-29 |
4 |
D |
$71.64 |
$28,226 |
D/D |
(394) |
36,930 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-04-28 |
4 |
D |
$71.64 |
$47,712 |
D/D |
(666) |
38,083 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-04-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
759 |
37,324 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
